Forum Financial Management LP Buys 2,282 Shares of Danaher Co. (NYSE:DHR)

Forum Financial Management LP boosted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 38.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,202 shares of the conglomerate's stock after acquiring an additional 2,282 shares during the period. Forum Financial Management LP's holdings in Danaher were worth $1,883,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in DHR. Norges Bank bought a new stake in Danaher in the 4th quarter valued at $2,130,740,000. Raymond James Financial Inc. bought a new stake in Danaher in the 4th quarter valued at $391,172,000. Two Sigma Advisers LP raised its stake in Danaher by 4,248.8% in the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock valued at $376,347,000 after acquiring an additional 1,601,800 shares during the period. Capital World Investors raised its stake in Danaher by 32.7% in the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after acquiring an additional 1,566,658 shares during the period. Finally, Point72 Asset Management L.P. raised its stake in Danaher by 460.6% in the 4th quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock valued at $309,558,000 after acquiring an additional 1,107,998 shares during the period. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of DHR traded down $0.22 during trading hours on Wednesday, hitting $188.96. 2,879,158 shares of the company were exchanged, compared to its average volume of 3,471,032. The company has a market cap of $135.23 billion, a price-to-earnings ratio of 35.79, a P/E/G ratio of 2.66 and a beta of 0.80. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm's fifty day moving average is $194.08 and its 200 day moving average is $214.67.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.82% and a net margin of 16.33%. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's dividend payout ratio (DPR) is presently 24.85%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research note on Tuesday, April 22nd. Barclays increased their price objective on Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 22nd. Raymond James reiterated a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. UBS Group lowered their price objective on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a research report on Wednesday, April 23rd. Finally, Guggenheim reiterated a "buy" rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $263.24.

Insider Activity at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total value of $3,129,390.00. Following the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.